Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial
- DOI
- 10.1016/s1470-2045(26)00446-8
- Published
- 2026-11
- Container
- The Lancet Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-26-00446-8,
title = {Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial},
author = {Kaixiong Tao and Zhenyu Lin and Peng Zhang and Pan Chi and Yi Xiao and Zhiguo Hou and Ximing Xu and Aimin Zhang and Xingfeng Qiu and Junxin Wu and Ying Yuan and Zhenning Wang and Xiujuan Qu and Xin Li and Xiu Nie and Ming Yang and Kailin Cai and Zheng Wang and Weikang Zhang and Ying Huang and Zhen Sun and Rongrong Zheng and Feng Zhao and Chuyi Han and Tao Zhang},
year = {2026},
journal = {The Lancet Oncology},
doi = {10.1016/s1470-2045(26)00446-8},
url = {https://doi.org/10.1016/s1470-2045(26)00446-8}
}RIS
TY - JOUR TI - Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial AU - Kaixiong Tao AU - Zhenyu Lin AU - Peng Zhang AU - Pan Chi AU - Yi Xiao AU - Zhiguo Hou AU - Ximing Xu AU - Aimin Zhang AU - Xingfeng Qiu AU - Junxin Wu AU - Ying Yuan AU - Zhenning Wang AU - Xiujuan Qu AU - Xin Li AU - Xiu Nie AU - Ming Yang AU - Kailin Cai AU - Zheng Wang AU - Weikang Zhang AU - Ying Huang AU - Zhen Sun AU - Rongrong Zheng AU - Feng Zhao AU - Chuyi Han AU - Tao Zhang PY - 2026 JO - The Lancet Oncology DO - 10.1016/s1470-2045(26)00446-8 UR - https://doi.org/10.1016/s1470-2045(26)00446-8 ER -
APA
Tao, K., Lin, Z., Zhang, P., Chi, P., Xiao, Y., Hou, Z., Xu, X., Zhang, A., Qiu, X., Wu, J., Yuan, Y., Wang, Z., Qu, X., Li, X., Nie, X., Yang, M., Cai, K., Wang, Z., Zhang, W., Huang, Y., Sun, Z., Zheng, R., Zhao, F., Han, C., & Zhang, T. (2026). Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(26)00446-8
Source records
- crossref · retrieved 2026-11-05T11:59:30.081Z